|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash and due from banks | ||||||||||||||
| Fed funds sold | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Marketable equity securities, stated at fair value | ||||||||||||||
| Available-for-sale securities, stated at fair value (amortized cost $107,383 and $119,055) | ||||||||||||||
| Loans held for sale | ||||||||||||||
| Loans, net of deferred costs | ||||||||||||||
| Allowance for credit losses for loans | ||||||||||||||
| Total loans, net of deferred loan costs and allowance for credit losses | ||||||||||||||
| Premises and equipment, net | ||||||||||||||
| Mortgage servicing rights, net | ||||||||||||||
| Federal Home Loan Bank (FHLB) stock, at cost | ||||||||||||||
| Accrued interest receivable | ||||||||||||||
| Cash value of life insurance | ||||||||||||||
| Other assets | ||||||||||||||
| TOTAL ASSETS | ||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||
| Deposits | ||||||||||||||
| Advance payments by borrowers for taxes and insurance | ||||||||||||||
| FHLB advances | ||||||||||||||
| Accrued interest payable | ||||||||||||||
| Other liabilities | ||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||
| Preferred stock, $0.01 par value, 10,000,000 shares authorized at September 30, 2024 and December 31, 2023 | ||||||||||||||
| Common stock (par value $0.01 per share) Authorized - 90,000,000 shares at September 30, 2024 and December 31, 2023; Issued - 5,994,977 at September 30, 2024 and 6,114,183 at December 31, 2023 (includes 115,574 and 144,297 unvested shares, respectively); Outstanding - 5,965,459 at September 30, 2024 and 6,084,665 at December 31, 2023 (includes 115,574 and 144,297 unvested shares, respectively) | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Unallocated common stock of Employee Stock Ownership Plan (ESOP), 419,291 and 434,062 shares at September 30, 2024 and December 31, 2023, respectively | ||||||||||||||
| Less treasury stock at cost, 29,518 shares at September 30, 2024 and December 31, 2023 | ||||||||||||||
| Retained earnings | ||||||||||||||
| Accumulated other comprehensive loss, net of income taxes | ||||||||||||||
| Total stockholders' equity | ||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
